Genetics
Global

Genetics Experts

Kevin Whaley

CEO
Biotechnology
Mapp Biopharmaceutical Inc
United States of America

Biography

Kevin Whaley has worked for the last 30 years on the development of multipurpose prevention technologies (MPTs), i.e. products that simultaneously prevent sexually transmitted diseases and unwanted pregnancy. He co-founded Mapp to develop antibody-based MPTs, therapeutics and mucosal vaccines that are appropriate for large, cost-sensitive, global health markets.   

Research Interest

 Biotechnology

Global Experts from United States of America

Global Experts in Subject

Share This Profile